AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
FOLD on Nasdaq
Shares outstanding
308,713,740
Price per share
$14.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
312,156,065
Total reported value
$2,459,923,997
% of total 13F portfolios
0.01%
Share change
-7,706,936
Value change
-$41,517,551
Number of holders
282
Price from insider filings
$14.24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $274,137,801 30,871,374 The Vanguard Group 28 Nov 2025
WELLINGTON MANAGEMENT GROUP LLP 9.5% $184,433,721 28,461,994 Wellington Management Group LLP 31 Dec 2024
BlackRock, Inc. 7.4% -21% $147,522,410 -$33,297,687 22,765,804 -18% BlackRock, Inc. 31 Mar 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 5.2% +6% $125,877,122 +$9,421,352 15,974,254 +8.1% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 30 Sep 2025
Avoro Capital Advisors LLC 4.9% -26% $118,397,000 -$43,143,000 15,025,000 -27% Avoro Capital Advisors LLC 30 Sep 2025
Redmile Group, LLC 4.6% $91,915,528 14,184,495 Redmile Group, LLC 31 Dec 2024
PERCEPTIVE ADVISORS LLC 2.4% -66% $54,854,942 -$103,982,558 7,412,830 -65% Perceptive Advisors LLC 30 Jun 2025

As of 30 Sep 2025, 282 institutional investors reported holding 312,156,065 shares of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD). This represents 101% of the company’s total 308,713,740 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.6% 29,534,029 +0.43% 0% $232,728,149
WELLINGTON MANAGEMENT GROUP LLP 9.3% 28,628,829 -1.7% 0.04% $225,595,173
BlackRock, Inc. 8.4% 25,848,965 -6.1% 0% $203,689,844
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 5.1% 15,749,240 +7.6% 0.32% $124,104,011
Avoro Capital Advisors LLC 4.9% 15,025,000 -17% 1.5% $118,397,000
MILLENNIUM MANAGEMENT LLC 3.8% 11,809,796 +59% 0.07% $93,061,192
STATE STREET CORP 3.7% 11,562,939 -0.04% 0% $91,115,959
Vestal Point Capital, LP 3.2% 9,750,000 -18% 3.5% $76,830,000
CITADEL ADVISORS LLC 2.7% 8,250,140 +38% 0.05% $65,011,103
Point72 Asset Management, L.P. 2.3% 7,156,557 +118% 0.12% $56,393,679
BANK OF AMERICA CORP /DE/ 2.3% 7,109,070 +3.8% 0% $56,019,468
GEODE CAPITAL MANAGEMENT, LLC 2.3% 7,099,093 +5.9% 0% $55,950,545
Pictet Asset Management Holding SA 2.2% 6,788,164 +74% 0.05% $53,619,642
PERCEPTIVE ADVISORS LLC 2.1% 6,370,851 -14% 1.5% $50,202,306
Palo Alto Investors LP 1.7% 5,367,798 -4.3% 7.8% $42,298,248
Soleus Capital Management, L.P. 1.5% 4,690,000 2% $36,957,200
Nuveen, LLC 1.5% 4,622,397 +27% 0.01% $36,424,489
MACQUARIE GROUP LTD 1.5% 4,560,810 -41% 0.04% $35,939,000
D. E. Shaw & Co., Inc. 1.3% 3,868,210 -39% 0.02% $30,481,495
GOLDMAN SACHS GROUP INC 1.2% 3,784,218 -13% 0% $29,819,639
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.2% 3,708,738 -0.48% 0.01% $29,224,855
RICE HALL JAMES & ASSOCIATES, LLC 1.1% 3,434,717 +24% 1.5% $27,065,570
NORTHERN TRUST CORP 1.1% 3,337,375 +8% 0% $26,298,515
MORGAN STANLEY 1% 3,198,670 -25% 0% $25,205,520
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.89% 2,752,098 +8% 0% $21,686,532

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 492,854 $7,020,197 -$22,549,783 $14.24 9
2025 Q3 312,156,065 $2,459,923,997 -$41,517,551 $7.88 282
2025 Q2 319,344,550 $1,830,820,509 +$26,198,276 $5.73 269
2025 Q1 309,375,837 $2,526,126,436 +$26,438,042 $8.16 280
2024 Q4 305,055,395 $2,873,666,151 -$29,117,094 $9.42 285
2024 Q3 306,817,206 $3,276,864,318 -$104,055,273 $10.68 287
2024 Q2 315,016,356 $3,125,028,962 -$32,282,639 $9.92 255
2024 Q1 317,334,392 $3,738,320,322 +$16,447,923 $11.78 252
2023 Q4 2,037,971 $28,957,367 +$5,448,591 $14.19 5
2023 Q3 296,152,783 $3,600,543,528 -$89,741,475 $12.16 224
2023 Q2 303,516,865 $3,812,151,638 +$91,969,469 $12.56 208
2023 Q1 297,231,224 $3,295,863,806 +$67,134,100 $11.09 219
2022 Q4 291,282,348 $3,556,372,840 +$7,367,179 $12.21 219
2022 Q3 285,323,318 $2,974,995,961 -$129,427,203 $10.44 213
2022 Q2 286,697,684 $3,079,035,531 +$13,575,168 $10.74 194
2022 Q1 270,127,079 $2,558,597,360 -$16,659,417 $9.47 195
2021 Q4 298,763,127 $3,449,199,142 +$92,194,156 $11.55 210
2021 Q3 292,599,727 $2,797,177,547 +$155,399,557 $9.55 224
2021 Q2 276,637,006 $2,667,083,732 +$5,137,314 $9.64 222
2021 Q1 275,160,380 $2,718,263,774 -$250,526,278 $9.88 239
2020 Q4 275,521,752 $6,361,479,072 +$51,010,655 $23.09 262
2020 Q3 277,254,404 $3,914,156,843 -$60,292,550 $14.12 234
2020 Q2 281,352,711 $4,243,669,403 +$8,670,983 $15.08 212
2020 Q1 280,864,056 $2,594,548,494 +$73,297,780 $9.24 184
2019 Q4 272,603,167 $2,654,976,187 +$16,329,108 $9.74 205
2019 Q3 270,165,771 $2,166,293,726 +$42,097,908 $8.02 190
2019 Q2 268,491,641 $3,349,541,275 +$271,186,923 $12.48 197
2019 Q1 249,680,307 $3,395,491,736 +$286,627,774 $13.60 193
2018 Q4 228,258,185 $2,179,404,816 +$17,577,948 $9.58 175
2018 Q3 225,358,031 $2,724,712,376 +$35,834,357 $12.09 194
2018 Q2 221,325,963 $3,457,038,017 +$48,693,256 $15.62 194
2018 Q1 224,631,937 $3,376,718,825 +$286,531,070 $15.04 197
2017 Q4 205,784,378 $2,961,545,572 +$69,146,736 $14.39 179
2017 Q3 198,392,754 $2,990,814,396 +$373,873,016 $15.08 180
2017 Q2 174,102,164 $1,753,181,994 +$127,444,082 $10.07 136
2017 Q1 168,794,799 $1,203,523,835 +$168,152,812 $7.13 128
2016 Q4 156,858,667 $779,548,508 +$23,503,698 $4.97 130
2016 Q3 148,308,742 $1,096,923,417 +$112,669,178 $7.40 134
2016 Q2 136,917,771 $747,537,873 -$24,942,072 $5.46 124
2016 Q1 138,569,762 $1,170,433,113 +$7,436,755 $8.45 125
2015 Q4 138,735,633 $1,345,655,641 +$34,284,690 $9.70 136
2015 Q3 127,133,976 $1,751,794,682 +$191,859,674 $13.99 142
2015 Q2 112,229,364 $1,587,846,319 +$450,201,410 $14.15 133
2015 Q1 81,958,495 $889,840,041 +$47,705,344 $10.88 124
2014 Q4 79,539,720 $661,682,201 +$234,242,681 $8.32 107
2014 Q3 46,781,517 $278,351,000 +$45,508,921 $5.95 93
2014 Q2 40,013,592 $133,633,107 +$27,002,831 $3.34 59
2014 Q1 34,301,232 $71,016,802 -$353,824 $2.07 67